Non-HACEK gram-negative bacilli endocarditis: a multicentre retrospective case-control study

Abstract Background Infective endocarditis (IE) caused by non-HACEK gram-negative bacilli (GNB) is poorly characterised and may be emerging as a consequence of medical progress. Methods We performed an observational retrospective case-control study. Cases were non-HACEK GNB IE, definite or possible (modified Duke criteria), diagnosed in adults between 2007 and 2020 in six French referral hospitals. Two controls were included for each case (IE due to other bacteria, matched by sites and diagnosis date). Results Non-HACEK GNB were identified in 2.4% (77/3230) of all IE during the study period, with a mean age of 69.2 ± 14.6 years, and a large male predominance (53/77, 69%). Primary pathogens were Escherichia coli (n = 33), Klebsiella sp. (n = 12) and Serratia marcescens (n = 9), including eight (10%) multidrug-resistant GNB. Compared to controls (n = 154: 43% Streptococcus sp., 41% Staphylococcus sp. and 12% Enterococcus sp.), non-HACEK GNB IE were independently associated with intravenous drug use (IVDU, 8% vs. 2%, p = .003), active neoplasia (15% vs. 6%, p = .009), haemodialysis (9% vs. 3%, p = .007) and healthcare-associated IE (36% vs. 18%, p = .002). Urinary tract was the main source of infection (n = 25, 33%) and recent invasive procedures were reported in 29% of cases. Non-HACEK GNB IE were at lower risk of embolism (31% vs. 47%, p = .002). One-year mortality was high (n = 28, 36%). Comorbidities, particularly malignant hemopathy and cirrhosis, were associated with increased risk of death. Conclusions Non-HACEK GNB are rarely responsible for IE, mostly as healthcare-associated IE in patients with complex comorbidities (end-stage renal disease, neoplasia), or in IVDUs.

[1]  J. Lo-Ten-Foe,et al.  Infective endocarditis caused by Enterobacteriaceae: phenotypic and molecular characterization of Escherichia coli and Klebsiella pneumoniae in Rio de Janeiro, Brazil , 2021, Brazilian Journal of Microbiology.

[2]  M. Veve,et al.  Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States , 2020, PloS one.

[3]  Mariano Vrancic,et al.  [Infective endocarditis due to non-HACEK gram-negative bacilli in a Level III cardiovascular center in Argentina (1998-2016)]. , 2019, Revista Argentina de microbiologia.

[4]  A. Mert,et al.  Non-HACEK Gram-negative bacillus endocarditis. , 2019, Medecine et maladies infectieuses.

[5]  Andrew Jones,et al.  Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Venditti,et al.  A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam , 2018, Infection.

[7]  M. Bassetti,et al.  Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort , 2018, Antimicrobial Agents and Chemotherapy.

[8]  José Luis Bernal,et al.  The Evolving Nature of Infective Endocarditis in Spain: A Population-Based Study (2003 to 2014). , 2017, Journal of the American College of Cardiology.

[9]  A. Kousoulis,et al.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.

[11]  G. Egmann,et al.  HACEK endocarditis: state-of-the-art , 2016, Expert review of anti-infective therapy.

[12]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[13]  A. Bolger,et al.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association , 2015, Circulation.

[14]  Y. Yazdanpanah,et al.  Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome , 2015, Infectious diseases.

[15]  J. Mehta,et al.  Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. , 2015, Journal of the American College of Cardiology.

[16]  F. Agrusta,et al.  Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years. , 2014, European journal of internal medicine.

[17]  V. Hricák,et al.  Endocarditis due to Gram-negative bacteria. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[18]  R. Darouiche,et al.  Nonstaphylococcal Infections of Cardiac Implantable Electronic Devices , 2010, Circulation.

[19]  R. Mendes,et al.  Resurgence of Pseudomonas Endocarditis in Detroit, 2006-2008 , 2009, Medicine.

[20]  Andrew Wang,et al.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.

[21]  Pierre Tattevin,et al.  Non-HACEK Gram-Negative Bacillus Endocarditis , 2007, Annals of Internal Medicine.

[22]  E. Bingen,et al.  Escherichia coli native valve endocarditis. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  M. Wolff,et al.  Native-valve infective endocarditis caused by Enterobacteriaceae: Report on 9 cases and literature review , 2006, Scandinavian journal of infectious diseases.

[24]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  O C Tablan,et al.  Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. , 1990, Reviews of infectious diseases.

[26]  M. Lederman,et al.  Left‐Sided Endocarditis due to Pseudomonas aeruginosa: A REPORT OF 10 CASES AND REVIEW OF THE LITERATURE , 1986, Medicine.

[27]  J. Valone,et al.  Experimental infective endocarditis. , 1979, Progress in cardiovascular diseases.

[28]  J. Rosenblatt,et al.  Gram-negative bacterial endocarditis in narcotic addicts. , 1973, California medicine.

[29]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[31]  P S Cohen,et al.  Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. , 1980, Progress in cardiovascular diseases.